Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family.
The molecular basis of the uroporphyrinogen III synthase (UROIIIS) deficiency was investigated in a member of a Japanese family. This defect in heme biosynthesis is responsible for a rare autosomal recessive disease: congenital erythropoietic porphyria (CEP) or Günther's disease. The patient was homozygous for a novel missense mutation: a G to T transition of nucleotide 7 that predicted a valine to phenylalanine substitution at residue 3 (V3F). The parents were heterozygous for the same mutation. The loss of UROIIIS activity was verified by an in vitro assay system. The corresponding mutated protein was expressed in Escherichia coli and no residual activity was observed. Further studies are needed to determine whether the mutations of the UROIIIS gene (UROS) have a specific profile in Japan compared to European or American countries.
Takamura
N
N
Department of Preventive Medicine, Atomic Disease Institute, Nagasaki University School of Medicine, Sakamoto, Japan.
Hombrados
I
I
Tanigawa
K
K
Namba
H
H
Nagayama
Y
Y
de Verneuil
H
H
Yamashita
S
S
D000328:Adult; D003001:Cloning, Molecular; D004926:Escherichia coli / Q000235:genetics; D006720:Homozygote; D006801:Humans; D007564:Japan; D008297:Male; D010375:Pedigree; D017354:Point Mutation; D017092:Porphyria, Erythropoietic / Q000235:genetics*; D014576:Uroporphyrinogen III Synthetase / Q000235:genetics*
D014576:Uroporphyrinogen III Synthetase